Overview
- 6 inspections across 5 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-27.
At a glance
Inspections
6
Sites
5
Observations
0
Career since
Oct 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Benefit Coatings Inc. | 27 Mar 2026 | Human Drugs | |
| Akeso Biopharma Co., Ltd. | 4 Mar 2025 | Human Drugs | On file |
| Apitoria Pharma Private Limited | 27 Sep 2024 | Human Drugs | On file |
| Aspen Biopharma Labs Pvt Ltd | 21 Sep 2024 | Human Drugs | On file |
| Exela Pharma Sciences, LLC. | 22 Oct 2019 | Human Drugs |
Sites inspected
Benefit Coatings Inc.Stratford, United States1 insp.
Akeso Biopharma Co., Ltd.Zhongshan, China1 insp.
Apitoria Pharma Private LimitedSangareddy District, India1 insp.
Aspen Biopharma Labs Pvt LtdMedchal Malkajgiri, India1 insp.
Exela Pharma Sciences, LLC.Lenoir, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Pushpa S Jayasekara2 shared
Cassandra L Abellard2 shared
Adam R Cooke2 shared
Raihan A Chowdhury1 shared
Samir C Gala1 shared
Charles Y Kuo1 shared
Yun Wu1 shared
Thuy T Nguyen1 shared
Full investigator report
Get the verbatim findings behind Khalid M Khan's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site